Cargando…
Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer
SIMPLE SUMMARY: Pancreatic cancer is one of the most heterogeneous and aggressive tumours that exist. The median survival of diagnosed patients is limited. For all these reasons, it is necessary to develop new disease markers that allow guidelines for clinical action to improve the average survival...
Autores principales: | Pekarek, Leonel, Fraile-Martinez, Oscar, Garcia-Montero, Cielo, Saez, Miguel A., Barquero-Pozanco, Ines, del Hierro-Marlasca, Laura, de Castro Martinez, Patricia, Romero-Bazán, Adoración, Alvarez-Mon, Miguel A., Monserrat, Jorge, García-Honduvilla, Natalio, Buján, Julia, Alvarez-Mon, Melchor, Guijarro, Luis G., Ortega, Miguel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029823/ https://www.ncbi.nlm.nih.gov/pubmed/35454771 http://dx.doi.org/10.3390/cancers14081866 |
Ejemplares similares
-
Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer
por: Ortega, Miguel A., et al.
Publicado: (2022) -
Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies
por: Ortega, Miguel A., et al.
Publicado: (2022) -
Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management
por: Ortega, Miguel A., et al.
Publicado: (2021) -
Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives
por: Pekarek, Leonel, et al.
Publicado: (2021) -
Tissue remodelling and increased DNA damage in patients with incompetent valves in chronic venous insufficiency
por: Ortega, Miguel A., et al.
Publicado: (2021)